Medical research

Institute working to accelerate COVID-19 drug development

As part of ongoing efforts to make a live attenuated vaccine for COVID-19, Texas Biomedical Research Institute Professor Luis Martinez-Sobrido and his team developed a weakened, or attenuated, version of SARS-CoV-2 that does ...

Medical research

Scientists discover clue to stopping Lassa virus infection

Lassa fever is a viral illness that is far too common in West Africa. Although it can have a mortality rate of 15% in severe cases, up to 90% in pregnant women, and causes deafness in a quarter of survivors, there is no vaccine ...

Diseases, Conditions, Syndromes

Examining COVID-19 and its many sublineages

As new omicron subvariants of COVID-19 continue to sweep across the United States, researchers at the University of Missouri have identified specific mutations within the virus' spike protein that help omicron subvariants ...

Diseases, Conditions, Syndromes

Experts urge Germany's govt to prepare for fall COVID wave

Authorities in Germany should prepare for several possible pandemic scenarios this fall that would likely strain the country's health system and critical infrastructure, an expert panel said Wednesday.

page 7 from 37